BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10509609)

  • 1. The yellow mouse obesity syndrome and mechanisms of agouti-induced obesity.
    Moussa NM; Claycombe KJ
    Obes Res; 1999 Sep; 7(5):506-14. PubMed ID: 10509609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of leptin by agouti.
    Claycombe KJ; Xue BZ; Mynatt RL; Zemel MB; Moustaid-Moussa N
    Physiol Genomics; 2000 Apr; 2(3):101-5. PubMed ID: 11015588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
    Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
    Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome.
    Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD
    Mol Endocrinol; 1997 May; 11(5):630-7. PubMed ID: 9139806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the agouti gene in the yellow obese syndrome.
    Miltenberger RJ; Mynatt RL; Wilkinson JE; Woychik RP
    J Nutr; 1997 Sep; 127(9):1902S-1907S. PubMed ID: 9278579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
    Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
    Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-opiomelanocortin and weight regulation: from mice to men.
    Boston BA
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1409-16. PubMed ID: 11837494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agouti/melanocortin interactions with leptin pathways in obesity.
    Zemel MB
    Nutr Rev; 1998 Sep; 56(9):271-4. PubMed ID: 9763877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agouti regulation of intracellular calcium: role of melanocortin receptors.
    Kim JH; Kiefer LL; Woychik RP; Wilkison WO; Truesdale A; Ittoop O; Willard D; Nichols J; Zemel MB
    Am J Physiol; 1997 Mar; 272(3 Pt 1):E379-84. PubMed ID: 9124542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
    Ebihara K; Ogawa Y; Katsuura G; Numata Y; Masuzaki H; Satoh N; Tamaki M; Yoshioka T; Hayase M; Matsuoka N; Aizawa-Abe M; Yoshimasa Y; Nakao K
    Diabetes; 1999 Oct; 48(10):2028-33. PubMed ID: 10512369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
    Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
    Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
    Mountjoy KG; Willard DH; Wilkison WO
    Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice.
    Miltenberger RJ; Mynatt RL; Bruce BD; Wilkison WO; Woychik RP; Michaud EJ
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8579-84. PubMed ID: 10411918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the melanocortin system and the melanocortin-4 receptor in ring dove (Streptopelia risoria) feeding behavior.
    Strader AD; Schiƶth HB; Buntin JD
    Brain Res; 2003 Jan; 960(1-2):112-21. PubMed ID: 12505663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and anatomical circuitry between Agouti-related protein and leptin signaling.
    Wilson BD; Bagnol D; Kaelin CB; Ollmann MM; Gantz I; Watson SJ; Barsh GS
    Endocrinology; 1999 May; 140(5):2387-97. PubMed ID: 10218993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells.
    Mountjoy KG; Kong PL; Taylor JA; Willard DH; Wilkison WO
    Physiol Genomics; 2001 Feb; 5(1):11-9. PubMed ID: 11161002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
    Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
    J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agouti: from mouse to man, from skin to fat.
    Voisey J; van Daal A
    Pigment Cell Res; 2002 Feb; 15(1):10-8. PubMed ID: 11837451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism.
    Xue B; Moustaid-N ; Wilkison WO; Zemel MB
    FASEB J; 1998 Oct; 12(13):1391-6. PubMed ID: 9761782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mahogany (mg) stimulates feeding and increases basal metabolic rate independent of its suppression of agouti.
    Dinulescu DM; Fan W; Boston BA; McCall K; Lamoreux ML; Moore KJ; Montagno J; Cone RD
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12707-12. PubMed ID: 9770550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.